Pharmacokinetic properties of azithromycin in pregnancy

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 1, 2010, Pages 360-366

  Salman, Sam ^a   Rogerson, Stephen J ^b   Kose, Kay ^c   Griffin, Susan ^c   Gomorai, Servina ^c   Baiwog, Francesca ^c   Winmai, Josephine ^c   Kandai, Josin ^c   Karunajeewa, Harin A ^a,d   O'Halloran, Sean J ^e   Siba, Peter ^c   Ilett, Kenneth F ^a,e   Mueller, Ivo ^c   Davis, Timothy M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^d WESTERN HEALTH   (Australia)

^e PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CHLOROQUINE; FANSIDAR;

ABDOMINAL PAIN; ADULT; ANEMIA; ANOREXIA; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; BONE PAIN; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DIZZINESS; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG ERUPTION; DRUG FEVER; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG INTERMITTENT THERAPY; DRUG SAFETY; DRUG TOLERABILITY; EAR DISEASE; FEMALE; HUMAN; HYPOGLYCEMIA; INSOMNIA; MALARIA CONTROL; MALARIA FALCIPARUM; NAUSEA; ORTHOSTATIC HYPOTENSION; PAPUA NEW GUINEA; PARESTHESIA; PLASMA CONCENTRATION-TIME CURVE; PLASMODIUM VIVAX MALARIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ADULT; ANTIMALARIALS; AREA UNDER CURVE; AZITHROMYCIN; CHLOROQUINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMBINATIONS; FEMALE; HALF-LIFE; HUMANS; INTESTINAL ABSORPTION; MODELS, STATISTICAL; PAPUA NEW GUINEA; PREGNANCY; PYRIMETHAMINE; SULFADOXINE; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 73849116378     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00771-09     Document Type: Article

References (45)

1. Adebayo, R. A., G. G. Sofowora, O. Onayemi, S. J. Udoh, and A. A. Ajayi. 1997. Chloroquine-induced pruritus in malaria fever: contribution of malaria parasitaemia and the effects of prednisolone, niacin, and their combination, compared with antihistamine. Br. J. Clin. Pharmacol. 44:157-161.
2. Amsden, G. W., and C. L. Gray. 2001. Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers. J. Antimicrob. Chemother. 47:61-66.
3. Anderson, B. J., and N. H. Holford. 2008. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu. Rev. Pharmacol. Toxicol. 48:303-332.
4. Anderson, G. D. 2005. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin. Pharmacokinet. 44:989-1008.
5. Anderson, S. L., A. J. Oloo, D. M. Gordon, O. B. Ragama, G. M. Aleman, J. D. German, D. B. Tang, M. W. Dunne, and G. D. Shanks. 1998. Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in Western Kenya. Clin. Infect. Dis. 26:146-150.
6. Ballow, C. H., G. W. Amsden, V. S. Highet, and A. Forrest. 1998. Pharmacokinetics of oral azithromycin in serum, urine, polymorphonuclear leucocytes and inflammatory vs non-inflammatory skin blisters in healthy volunteers. Clin. Drug Investig. 15:159-167.
7. Boonleang, J., K. Panrat, C. Tantana, S. Krittathanmakul, and W. Jintapakorn. 2007. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers. Clin. Ther. 29:703-710.
8. Centers for Disease Control and Prevention. 2006. Sexually transmitted diseases treatment guidelines, 2006: diseases characterized by urethritis and cervicitis. MMWR Morb. Mortal. Wkly. Rep. 55:35-49.
9. Chandra, R., P. Liu, J. D. Breen, J. Fisher, C. Xie, R. LaBadie, R. J. Benner, L. J. Benincosa, and A. Sharma. 2007. Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin. Clin. Pharmacokinet. 46:247-259.
10. Chico, R. M., R. Pittrof, B. Greenwood, and D. Chandramohan. 2008. Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy. Malar. J. 7:255.
11. Cook, J. A., E. J. Randinitis, C. R. Bramson, and D. L. Wesche. 2006. Lack of a pharmacokinetic interaction between azithromycin and chloroquine. Am. J. Trop. Med. Hyg. 74:407-412.
12. Dunne, M. W., N. Singh, M. Shukla, N. Valecha, P. C. Bhattacharyya, V. Dev, K. Patel, M. K. Mohapatra, J. Lakhani, R. Benner, C. Lele, and K. Patki. 2005. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. J. Infect. Dis. 191:1582-1588.
13. Foulds, G., R. M. Shepard, and R. B. Johnson. 1990. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 25(Suppl. A):73-82.
14. Garner, P., and A. M. Gulmezoglu. 2003. Drugs for preventing malariarelated illness in pregnant women and death in the newborn. Cochrane Database Syst. Rev. CD000169. Accessed October 2009.
15. Gerhardy, C. L., and M. Garrett. 2002. Obstetrics and gynaecology for nurses and midwives, 5th ed. Lutheran School of Nursing, Madang, Papua New Guinea.
16. Heppner, D. G., Jr., D. S. Walsh, N. Uthaimongkol, D. B. Tang, S. Tulyayon, B. Permpanich, T. Wimonwattrawatee, N. Chuanak, A. Laoboonchai, P. Sookto, T. G. Brewer, P. McDaniel, C. Eamsila, K. Yongvanitchit, K. Uhl, D. E. Kyle, L. W. Keep, R. E. Miller, and C. Wongsrichanalai. 2005. Randomized, controlled, double-blind trial of daily oral azithromycin in adults for the prophylaxis of Plasmodium vivax malaria in Western Thailand. Am. J. Trop. Med. Hyg. 73:842-849.
17. Hodge, L. S., and T. S. Tracy. 2007. Alterations in drug disposition during pregnancy: implications for drug therapy. Exp. Opin. Drug Metab. Toxicol. 3:557-571.
18. Jonsson, E. N., and M. O. Karlsson. 1999. Xpose - an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput. Methods Programs Biomed. 58:51-64.
19. Kain, K. C., G. D. Shanks, and J. S. Keystone. 2001. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens. Clin. Infect. Dis. 33:226-234.
20. Kalilani, L., I. Mofolo, M. Chaponda, S. J. Rogerson, A. P. Alker, J. J. Kwiek, and S. R. Meshnick. 2007. A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women. PLoS One 2:e1166.
21. Krishna, S., and N. J. White. 1996. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin. Pharmacokinet. 30:263-299.
22. Lalak, N. J., and D. L. Morris. 1993. Azithromycin clinical pharmacokinetics. Clin. Pharmacokinet. 25:370-374.
23. Liu, P., H. Allaudeen, R. Chandra, K. Phillips, A. Jungnik, J. D. Breen, and A. Sharma. 2007. Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen. Antimicrob. Agents Chemother. 51:103-109.
24. Lucchi, M., B. Damle, A. Fang, P. J. de Caprariis, A. Mussi, S. P. Sanchez, G. Pasqualetti, and M. Del Tacca. 2008. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin. J. Antimicrob. Chemother. 61:884-891.
25. Luke, D. R., and G. Foulds. 1997. Disposition of oral azithromycin in humans. Clin. Pharmacol. Ther. 61:641-648.
26. Mazzei, T., C. Surrenti, A. Novelli, A. Crispo, S. Fallani, V. Carla, E. Surrenti, and P. Periti. 1993. Pharmacokinetics of azithromycin in patients with impaired hepatic function. J. Antimicrob. Chemother. 31(Suppl. E):57-63.
27. Miller, R. S., C. Wongsrichanalai, N. Buathong, P. McDaniel, D. S. Walsh, C. Knirsch, and C. Ohrt. 2006. Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study. Am. J. Trop. Med. Hyg. 74:401-406.
28. Nakornchai, S., and P. Konthiang. 2006. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro. Acta Trop. 100:185-191.
29. Noedl, H., S. Krudsood, K. Chalermratana, U. Silachamroon, W. Leowattana, N. Tangpukdee, S. Looareesuwan, R. S. Miller, M. Fukuda, K. Jongsakul, S. Sriwichai, J. Rowan, H. Bhattacharyya, C. Ohrt, and C. Knirsch. 2006. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Clin. Infect. Dis. 43:1264-1271.
30. Noedl, H., S. Krudsood, W. Leowattana, N. Tangpukdee, W. Thanachartwet, S. Looareesuwan, R. S. Miller, M. Fukuda, K. Jongsakul, K. Yingyuen, S. Sriwichai, C. Ohrt, and C. Knirsch. 2007. In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Antimicrob. Agents Chemother. 51:651-656.
31. Ohrt, C., G. D. Willingmyre, P. Lee, C. Knirsch, and W. Milhous. 2002. Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 46:2518-2524.
32. Oldfield, E. C., III, W. J. Fessel, M. W. Dunne, G. Dickinson, M. R. Wallace, W. Byrne, R. Chung, K. F. Wagner, S. F. Paparello, D. B. Craig, G. Melcher, M. Zajdowicz, R. F. Williams, J. W. Kelly, M. Zelasky, L. B. Heifets, and J. D. Berman. 1998. Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial. Clin. Infect. Dis. 26:611-619.
33. Periti, P., T. Mazzei, E. Mini, and A. Novelli. 1993. Adverse effects of macrolide antibacterials. Drug Saf. 9:346-364.
34. Peters, D. H., H. A. Friedel, and D. McTavish. 1992. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 44:750-799.
35. Pfizer. 2009. Zithromax U.S. physician prescribing information. Pfizer Labs, New York, NY.
36. Ramsey, P. S., M. B. Vaules, G. M. Vasdev, W. W. Andrews, and K. D. Ramin. 2003. Maternal and transplacental pharmacokinetics of azithromycin. Am. J. Obstet. Gynecol. 188:714-718.
37. Ripa, S., L. Ferrante, and M. Prenna. 1996. A linear model for the pharmacokinetics of azithromycin in healthy volunteers. Chemotherapy 42:402-409.
38. Sarkar, M., C. Woodland, G. Koren, and A. R. Einarson. 2006. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 6:18.
39. Schlitzer, M. 2007. Malaria chemotherapeutics. Part I: history of antimalarial drug development, currently used therapeutics, and drugs in clinical development. Chem. Med. Chem. 2:944-986.
40. Sidhu, A. B., Q. Sun, L. J. Nkrumah, M. W. Dunne, J. C. Sacchettini, and D. A. Fidock. 2007. In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin. J. Biol. Chem. 282:2494-2504.
41. Taylor, W. R., T. L. Richie, D. J. Fryauff, H. Picarima, C. Ohrt, D. Tang, D. Braitman, G. S. Murphy, H. Widjaja, E. Tjitra, A. Ganjar, T. R. Jones, H. Basri, and J. Berman. 1999. Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. Clin. Infect. Dis. 28:74-81.
42. Upton, R. N., and G. L. Ludbrook. 2005. Pharmacokinetic- pharmacodynamic modelling of the cardiovascular effects of drugs - method development and application to magnesium in sheep. BMC Pharmacol. 5:5.
43. van Eijk, A. M., and D. J. Terlouw. 2007. Azithromycin for treating uncomplicated malaria. Cochrane Database Syst. Rev. CD006688. Accessed October 2009.
44. White, N. J. 2005. Intermittent presumptive treatment for malaria. PLoS Med. 2:e3.
45. Wildfeuer, A., H. Laufen, M. Leitold, and T. Zimmermann. 1993. Comparison of the pharmacokinetics of three-day and five-day regimens of azithromycin in plasma and urine. J. Antimicrob. Chemother. 31(Suppl. E):51-56.